Clinical Disease Activity Index (CDAI) for Rheumatoid Arthritis

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۲۸ • واحد: joints

حداقل ۰ — حداکثر ۲۸ • واحد: joints

حداقل ۰ — حداکثر ۱۰ • واحد: 0-10 scale

حداقل ۰ — حداکثر ۱۰ • واحد: 0-10 scale

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
cdai score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Remission0–2.8
  • Low Disease Activity2.8–10
  • Moderate Disease Activity10–22
  • High Disease Activity22–76
Direct Clinical Answer

The Clinical Disease Activity Index (CDAI) for Rheumatoid Arthritis calculates classifying inflammatory arthritides and monitoring longitudinal autoimmune disease activity. Key inputs include tender joint count. Scores guide initiating or optimizing disease-modifying antirheumatic drugs (DMARDs) or targeted biologic therapies. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Determines severity of rheumatoid arthritis using only clinical data, without laboratory tests

Clinical Indication

The Clinical Disease Activity Index (CDAI) for Rheumatoid Arthritis is indicated for bedside clinical practice to support Determines severity of rheumatoid arthritis using only clinical data, without laboratory tests. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with inflammatory arthritis, systemic lupus erythematosus, systemic vasculitis, or autoimmune connective tissue disorders. Clinical application is indicated across Rheumatology clinics, connective tissue disease units, and academic medical centers.

Limitations & Contraindications

Elevated erythrocyte sedimentation rate (ESR) and CRP are non-specific acute phase reactants that can reflect occult systemic infection.

Clinical Pearls & Action Plan

Serological autoantibody testing must strictly correlate with inflammatory joint patterns and objective synovial pathology. Guideline pearl: Allows immediate treatment decisions without waiting for lab results.

Formula & Variables:

CDAI = Tender Joint Count (0-28) + Swollen Joint Count (0-28) + Patient Global Activity (0-10) + Provider Global Activity (0-10)

Input Parameters

NameTypeRequiredDescription
tender_joint_countintegerYesNumber of tender joints (28-joint count)(joints)
swollen_joint_countintegerYesNumber of swollen joints (28-joint count)(joints)
patient_global_activityfloatYesPatient global assessment of disease activity (0-10 scale)(0-10 scale)
provider_global_activityfloatYesProvider global assessment of disease activity (0-10 scale)(0-10 scale)

Score Interpretation & Guidance

RangeStageDescription
0–2.8RemissionDisease in remission
2.8–10Low Disease ActivityLow disease activity
10–22Moderate Disease ActivityModerate disease activity
22–76High Disease ActivityHigh disease activity

Evidence-Based References (EBM)

  • Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, Smolen JS. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther. 2005;7(4):R796-806.
  • Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, van Riel PL, Tugwell P. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford). 2003;42(2):244-57.
  • Aletaha D, Smolen JS. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol. 2005;23(5 Suppl 39):S100-8.

Related calculators